DexCom Price to Book Ratio 2010-2025 | DXCM
Historical price to book ratio values for DexCom (DXCM) over the last 10 years. The current price to book ratio for DexCom as of June 20, 2025 is 13.84.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| DexCom Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-06-20 | 80.00 | 13.84 | |
| 2025-03-31 | 68.29 | $5.78 | 11.81 |
| 2024-12-31 | 77.77 | $5.38 | 14.45 |
| 2024-09-30 | 67.04 | $5.07 | 13.23 |
| 2024-06-30 | 113.38 | $6.08 | 18.66 |
| 2024-03-31 | 138.70 | $5.67 | 24.45 |
| 2023-12-31 | 124.09 | $5.37 | 23.12 |
| 2023-09-30 | 93.30 | $5.87 | 15.90 |
| 2023-06-30 | 128.51 | $5.44 | 23.62 |
| 2023-03-31 | 116.18 | $5.76 | 20.17 |
| 2022-12-31 | 113.24 | $5.52 | 20.52 |
| 2022-09-30 | 80.54 | $4.72 | 17.05 |
| 2022-06-30 | 74.53 | $5.75 | 12.97 |
| 2022-03-31 | 127.90 | $5.58 | 22.92 |
| 2021-12-31 | 134.24 | $5.26 | 25.51 |
| 2021-09-30 | 136.72 | $5.51 | 24.81 |
| 2021-06-30 | 106.75 | $5.16 | 20.67 |
| 2021-03-31 | 89.85 | $4.92 | 18.26 |
| 2020-12-31 | 92.43 | $4.75 | 19.45 |
| 2020-09-30 | 103.06 | $3.90 | 26.40 |
| 2020-06-30 | 101.35 | $3.55 | 28.57 |
| 2020-03-31 | 67.32 | $2.53 | 26.60 |
| 2019-12-31 | 54.69 | $2.41 | 22.70 |
| 2019-09-30 | 37.31 | $2.09 | 17.87 |
| 2019-06-30 | 37.46 | $1.89 | 19.85 |
| 2019-03-31 | 29.78 | $1.84 | 16.21 |
| 2018-12-31 | 29.95 | $1.84 | 16.26 |
| 2018-09-30 | 35.76 | $1.58 | 22.59 |
| 2018-06-30 | 23.75 | $1.36 | 17.42 |
| 2018-03-31 | 18.54 | $1.20 | 15.49 |
| 2017-12-31 | 14.35 | $1.21 | 11.90 |
| 2017-09-30 | 12.23 | $1.10 | 11.07 |
| 2017-06-30 | 18.29 | $1.02 | 17.89 |
| 2017-03-31 | 21.18 | $0.80 | 26.32 |
| 2016-12-31 | 14.93 | $0.84 | 17.80 |
| 2016-09-30 | 21.92 | $0.77 | 28.29 |
| 2016-06-30 | 19.83 | $0.74 | 26.98 |
| 2016-03-31 | 16.98 | $0.69 | 24.50 |
| 2015-12-31 | 20.48 | $0.68 | 30.25 |
| 2015-09-30 | 21.47 | $0.59 | 36.11 |
| 2015-06-30 | 20.00 | $0.53 | 37.49 |
| 2015-03-31 | 15.59 | $0.48 | 32.56 |
| 2014-12-31 | 13.76 | $0.45 | 30.35 |
| 2014-09-30 | 10.00 | $0.38 | 26.57 |
| 2014-06-30 | 9.92 | $0.33 | 30.03 |
| 2014-03-31 | 10.34 | $0.30 | 34.38 |
| 2013-12-31 | 8.85 | $0.29 | 30.53 |
| 2013-09-30 | 7.06 | $0.26 | 27.08 |
| 2013-06-30 | 5.61 | $0.25 | 22.11 |
| 2013-03-31 | 4.18 | $0.26 | 16.06 |
| 2012-12-31 | 3.40 | $0.28 | 12.27 |
| 2012-09-30 | 3.76 | $0.29 | 12.97 |
| 2012-06-30 | 3.24 | $0.33 | 9.78 |
| 2012-03-31 | 2.61 | $0.36 | 7.18 |
| 2011-12-31 | 2.33 | $0.39 | 6.01 |
| 2011-09-30 | 3.00 | $0.42 | 7.16 |
| 2011-06-30 | 3.62 | $0.45 | 8.03 |
| 2011-03-31 | 3.88 | $0.21 | 18.14 |
| 2010-12-31 | 3.41 | $0.25 | 13.89 |
| 2010-09-30 | 3.31 | $0.15 | 22.02 |
| 2010-06-30 | 2.89 | $0.18 | 16.33 |
| 2010-03-31 | 2.44 | $0.20 | 11.97 |
| 2009-12-31 | 2.02 | $-0.10 | -20.15 |
| 2009-09-30 | 1.98 | $-0.05 | -40.13 |
| 2009-06-30 | 1.55 | $0.01 | 143.29 |
| 2009-03-31 | 1.04 | $0.08 | 12.62 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $31.369B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $182.564B | 79.96 |
| Thermo Fisher Scientific (TMO) | United States | $150.197B | 18.17 |
| Edwards Lifesciences (EW) | United States | $43.309B | 28.40 |
| IDEXX Laboratories (IDXX) | United States | $42.135B | 48.42 |
| Alcon (ALC) | Switzerland | $42.123B | 28.47 |
| IQVIA Holdings (IQV) | United States | $26.768B | 14.99 |
| Mettler-Toledo (MTD) | United States | $23.982B | 28.52 |
| STERIS (STE) | Ireland | $23.183B | 25.53 |
| Waters (WAT) | United States | $20.390B | 28.77 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.638B | 0.00 |
| Hologic (HOLX) | United States | $14.369B | 15.61 |
| Sysmex ADR (SSMXY) | Japan | $10.550B | 29.93 |
| Penumbra (PEN) | United States | $9.948B | 78.08 |
| Masimo (MASI) | United States | $8.956B | 33.04 |
| Globus Medical (GMED) | United States | $7.834B | 18.67 |
| Glaukos (GKOS) | United States | $5.723B | 0.00 |
| Teleflex (TFX) | United States | $5.228B | 8.63 |
| TransMedics (TMDX) | United States | $4.179B | 90.85 |
| Integer Holdings (ITGR) | United States | $4.110B | 21.54 |
| PROCEPT BioRobotics (PRCT) | United States | $3.332B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.481B | 14.78 |
| Nihon Kohden (NHNKY) | Japan | $2.265B | 25.98 |
| Veracyte (VCYT) | United States | $2.067B | 29.00 |
| Elekta AB (EKTAY) | Sweden | $1.901B | 17.09 |
| Alphatec Holdings (ATEC) | United States | $1.599B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.347B | 0.00 |
| Artivion (AORT) | United States | $1.292B | 121.00 |
| Pulse Biosciences (PLSE) | United States | $1.029B | 0.00 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.901B | 4.79 |
| Beta Bionics (BBNX) | United States | $0.776B | 0.00 |
| IRadimed (IRMD) | United States | $0.741B | 37.57 |
| SiBone (SIBN) | United States | $0.698B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 8.73 |
| RxSight (RXST) | United States | $0.553B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.523B | 12.25 |
| OrthoPediatrics (KIDS) | United States | $0.493B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.482B | 0.00 |
| AxoGen (AXGN) | United States | $0.443B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.407B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.405B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.403B | 10.72 |
| Pacific Biosciences Of California (PACB) | United States | $0.381B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.347B | 0.00 |
| NeuroPace (NPCE) | United States | $0.341B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.315B | 0.00 |
| 908 Devices (MASS) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.232B | 14.04 |
| Neuronetics (STIM) | United States | $0.228B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.210B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.204B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.183B | 0.00 |
| Inogen (INGN) | United States | $0.179B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.174B | 0.00 |
| CVRx (CVRX) | United States | $0.153B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.147B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.146B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| Accuray (ARAY) | United States | $0.126B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 47.30 |
| InspireMD (NSPR) | United States | $0.075B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.071B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.063B | 0.00 |
| Spectral AI (MDAI) | United States | $0.055B | 0.00 |
| Hyperfine (HYPR) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.050B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.047B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.043B | 0.00 | |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.32 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |